GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 209 filers reported holding GENMAB A/S in Q2 2021. The put-call ratio across all filers is 0.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $600,710 | -41.4% | 15,804 | -41.8% | 0.11% | -44.0% |
| Q1 2023 | $1,024,920 | -43.6% | 27,143 | -36.7% | 0.19% | -56.0% |
| Q4 2022 | $1,816,025 | +389.5% | 42,851 | +270.7% | 0.43% | +416.7% |
| Q3 2022 | $371,000 | -28.5% | 11,560 | -27.6% | 0.08% | -40.0% |
| Q2 2022 | $519,000 | -42.5% | 15,976 | -36.0% | 0.14% | -42.4% |
| Q1 2022 | $903,000 | +147.4% | 24,972 | +199.1% | 0.24% | +104.2% |
| Q3 2021 | $365,000 | +45.4% | 8,350 | +35.8% | 0.12% | +15.5% |
| Q2 2021 | $251,000 | – | 6,150 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 52,148 | $1,839,260 | 1.67% |
| Ativo Capital Management LLC | 28,442 | $1,003,132 | 1.13% |
| HARDING LOEVNER LP | 3,204,230 | $113,013,183 | 0.75% |
| Hardman Johnston Global Advisors LLC | 592,318 | $20,891,056 | 0.70% |
| Yorktown Management & Research Co Inc | 16,600 | $585,482 | 0.66% |
| TORRAY INVESTMENT PARTNERS LLC | 104,516 | $3,686,279 | 0.65% |
| First Light Asset Management, LLC | 157,147 | $5,542,575 | 0.53% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 44,300 | $1,561,575 | 0.53% |
| Capricorn Fund Managers Ltd | 37,007 | $1,305,237 | 0.45% |
| Legacy Wealth Asset Management, LLC | 29,496 | $1,040,324 | 0.38% |